Literature DB >> 19211304

Variation matters: TLR structure and species-specific pathogen recognition.

Dirk Werling1, Oliver C Jann, Victoria Offord, Elizabeth J Glass, Tracey J Coffey.   

Abstract

Toll-like receptors (TLRs) are a family of pattern recognition receptors that are an important link between innate and adaptive immunity. Many vaccines incorporate ligands for TLRs as an adjuvant and are developed in rodent models, with the resulting data transferred to other species. Vaccine features can be improved markedly by emphasizing the biological relevance when evaluating other animal models for host-pathogen interaction and by taking greater advantage of the unique experimental opportunities that are offered by large animal, non-rodent models. Here, we aim to summarize our current knowledge of species-specific TLR responses and briefly discuss that vaccine efficacy in relevant host species might be improved by considering the species-specific TLR responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211304     DOI: 10.1016/j.it.2008.12.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  79 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

2.  Positive selection pressure within teleost Toll-like receptors tlr21 and tlr22 subfamilies and their response to temperature stress and microbial components in zebrafish.

Authors:  Arvind Y M Sundaram; Sonia Consuegra; Viswanath Kiron; Jorge M O Fernandes
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 3.  Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Authors:  G Liu; L Zhang; Y Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-29       Impact factor: 4.330

4.  Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

Authors:  Daniel C Peltier; Allison Simms; Jocelyn R Farmer; David J Miller
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

5.  A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition.

Authors:  Jin Liu; Congfeng Xu; Li-Chung Hsu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Mol Immunol       Date:  2009-12-08       Impact factor: 4.407

6.  RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity.

Authors:  Meidi Gu; Zhiyong Liu; Rongrong Lai; Si Liu; Wenlong Lin; Chuan Ouyang; Sheng Ye; He Huang; Xiaojian Wang
Journal:  EMBO J       Date:  2016-10-17       Impact factor: 11.598

7.  European wild boars and domestic pigs display different polymorphic patterns in the Toll-like receptor (TLR) 1, TLR2, and TLR6 genes.

Authors:  Ingrid-Maria Bergman; Johan K Rosengren; Kjell Edman; Inger Edfors
Journal:  Immunogenetics       Date:  2009-12-02       Impact factor: 2.846

8.  Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer.

Authors:  Katja Farhat; Sabine Riekenberg; Günther Jung; Karl-Heinz Wiesmüller; Thomas W Jungi; Artur J Ulmer
Journal:  Vet Res       Date:  2010-01-26       Impact factor: 3.683

9.  Comparative genomics of Toll-like receptor signalling in five species.

Authors:  Oliver C Jann; Annemarie King; Nestor Lopez Corrales; Susan I Anderson; Kirsty Jensen; Tahar Ait-Ali; Haizhou Tang; Chunhua Wu; Noelle E Cockett; Alan L Archibald; Elizabeth J Glass
Journal:  BMC Genomics       Date:  2009-05-11       Impact factor: 3.969

10.  The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes.

Authors:  Philippe Georgel; Cécile Macquin; Seiamak Bahram
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.